Complex Information for Anesthesiologists Presented Quickly and Clearly
*ENIGMA II trial cardiac risk factors included history of coronary artery disease, heart failure, cerebrovascular disease, or peripheral vascular disease, or age ≥70 yr with other comorbiditiesInfographic created by Holly B. Ende, Vanderbilt University Medical Center; James P. Rathmell, Brigham and Women’s Health Care/Harvard Medical School; and Jonathan P. Wanderer, Vanderbilt University Medical Center. Illustration by Annemarie Johnson, Vivo Visuals Studio. Address correspondence to Dr. Ende: firstname.lastname@example.org.
and the ENIGMA Trial Group:
Avoidance of nitrous oxide for patients undergoing major surgery.
ANZCA Trials Group for the ENIGMA-II investigators:
The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): A randomised, single-blind trial.
Postoperative pulmonary complications in the ENIGMA II Trial: A post hoc analysis.
Copyright © 2023, the American Society of Anesthesiologists. All Rights Reserved.